| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 470.94B | 458.35B | 448.43B | 430.74B | 420.72B | 433.57B |
| Gross Profit | 51.62B | 48.49B | 50.14B | 47.75B | 52.75B | 73.41B |
| EBITDA | 20.57B | 20.55B | 23.18B | 20.90B | 24.55B | 31.54B |
| Net Income | 6.62B | 7.08B | 7.49B | 4.50B | 9.72B | 14.16B |
Balance Sheet | ||||||
| Total Assets | 256.28B | 239.61B | 244.79B | 229.89B | 221.72B | 214.54B |
| Cash, Cash Equivalents and Short-Term Investments | 11.67B | 12.42B | 15.36B | 17.90B | 20.58B | 32.98B |
| Total Debt | 19.76B | 22.07B | 21.71B | 25.41B | 20.45B | 22.15B |
| Total Liabilities | 124.28B | 109.38B | 114.58B | 106.69B | 99.15B | 99.78B |
| Stockholders Equity | 122.60B | 119.38B | 119.31B | 113.17B | 111.86B | 103.63B |
Cash Flow | ||||||
| Free Cash Flow | 7.60B | 5.06B | 12.10B | -6.47B | 2.08B | 17.41B |
| Operating Cash Flow | 17.83B | 14.21B | 22.54B | 11.72B | 16.74B | 27.25B |
| Investing Cash Flow | -13.25B | -13.57B | -19.43B | -15.09B | -23.71B | -12.21B |
| Financing Cash Flow | -5.79B | -4.20B | -7.57B | 1.21B | -6.62B | -7.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥32.21B | 9.72 | ― | 1.94% | 3.15% | 27.71% | |
69 Neutral | ¥164.81B | 9.61 | ― | 1.39% | 3.91% | -0.28% | |
68 Neutral | ¥16.78B | 2.44 | ― | 3.17% | 5.19% | 11.04% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥131.66B | 14.71 | ― | 3.02% | 2.16% | -24.33% | |
61 Neutral | ¥48.02B | 3.77 | ― | 0.52% | 20.97% | -56.39% | |
58 Neutral | ¥68.34B | 15.39 | ― | 1.48% | 8.41% | -3.65% |